Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 347

1.

Modelling community-control strategies to protect hospital resources during an influenza pandemic in Ottawa, Canada.

Saunders-Hastings P, Quinn Hayes B, Smith R, Krewski D.

PLoS One. 2017 Jun 14;12(6):e0179315. doi: 10.1371/journal.pone.0179315. eCollection 2017.

2.

Evaluating the effects of common control measures for influenza A (H1N1) outbreak at school in China: A modeling study.

Chen T, Huang Y, Liu R, Xie Z, Chen S, Hu G.

PLoS One. 2017 May 19;12(5):e0177672. doi: 10.1371/journal.pone.0177672. eCollection 2017.

3.

Interdisciplinary pharmacometrics linking oseltamivir pharmacology, influenza epidemiology and health economics to inform antiviral use in pandemics.

Kamal MA, Smith PF, Chaiyakunapruk N, Wu DBC, Pratoomsoot C, Lee KKC, Chong HY, Nelson RE, Nieforth K, Dall G, Toovey S, Kong DCM, Kamauu A, Kirkpatrick CM, Rayner CR.

Br J Clin Pharmacol. 2017 Jul;83(7):1580-1594. doi: 10.1111/bcp.13229. Epub 2017 Feb 20.

PMID:
28176362
4.

Dynamic-Sensitive centrality of nodes in temporal networks.

Huang DW, Yu ZG.

Sci Rep. 2017 Feb 2;7:41454. doi: 10.1038/srep41454.

5.

Stochastic modelling of infectious diseases for heterogeneous populations.

Ming RX, Liu JM, W Cheung WK, Wan X.

Infect Dis Poverty. 2016 Dec 22;5(1):107. doi: 10.1186/s40249-016-0199-5. Erratum in: Infect Dis Poverty. 2017 Feb 28;6(1):50.

6.

Parameter Scaling for Epidemic Size in a Spatial Epidemic Model with Mobile Individuals.

Urabe CT, Tanaka G, Aihara K, Mimura M.

PLoS One. 2016 Dec 14;11(12):e0168127. doi: 10.1371/journal.pone.0168127. eCollection 2016.

7.

Transmissibility of the Influenza Virus during Influenza Outbreaks and Related Asymptomatic Infection in Mainland China, 2005-2013.

Chen T, Chen T, Liu R, Xu C, Wang D, Chen F, Zhu W, Zhang X, Yang J, Wang L, Xie Z, Chen Y, Bai T, Li Y, Wang Z, Zhang M, Chen S, Shu Y.

PLoS One. 2016 Nov 23;11(11):e0166180. doi: 10.1371/journal.pone.0166180. eCollection 2016.

8.

The transmissibility estimation of influenza with early stage data of small-scale outbreaks in Changsha, China, 2005-2013.

Chen TM, Chen QP, Liu RC, Szot A, Chen SL, Zhao J, Zhou SS.

Epidemiol Infect. 2017 Feb;145(3):424-433. doi: 10.1017/S0950268816002508. Epub 2016 Nov 11.

9.

How social structures, space, and behaviors shape the spread of infectious diseases using chikungunya as a case study.

Salje H, Lessler J, Paul KK, Azman AS, Rahman MW, Rahman M, Cummings D, Gurley ES, Cauchemez S.

Proc Natl Acad Sci U S A. 2016 Nov 22;113(47):13420-13425. Epub 2016 Nov 7.

10.

Containing Ebola at the Source with Ring Vaccination.

Merler S, Ajelli M, Fumanelli L, Parlamento S, Pastore Y Piontti A, Dean NE, Putoto G, Carraro D, Longini IM Jr, Halloran ME, Vespignani A.

PLoS Negl Trop Dis. 2016 Nov 2;10(11):e0005093. doi: 10.1371/journal.pntd.0005093. eCollection 2016 Nov.

11.

Spotting Epidemic Keystones by R0 Sensitivity Analysis: High-Risk Stations in the Tokyo Metropolitan Area.

Yashima K, Sasaki A.

PLoS One. 2016 Sep 8;11(9):e0162406. doi: 10.1371/journal.pone.0162406. eCollection 2016.

12.

Scale Effects on Spatially Embedded Contact Networks.

Gao P, Bian L.

Comput Environ Urban Syst. 2016 Sep;59:142-151. Epub 2016 Jun 25.

PMID:
27482125
13.

Identifying cost-effective dynamic policies to control epidemics.

Yaesoubi R, Cohen T.

Stat Med. 2016 Dec 10;35(28):5189-5209. doi: 10.1002/sim.7047. Epub 2016 Jul 24.

PMID:
27449759
14.

Fine-grained dengue forecasting using telephone triage services.

Abdur Rehman N, Kalyanaraman S, Ahmad T, Pervaiz F, Saif U, Subramanian L.

Sci Adv. 2016 Jul 8;2(7):e1501215. doi: 10.1126/sciadv.1501215. eCollection 2016 Jul.

15.

Extrapolating theoretical efficacy of inactivated influenza A/H5N1 virus vaccine from human immunogenicity studies.

Feldstein LR, Matrajt L, Elizabeth Halloran M, Keitel WA, Longini IM Jr; H5N1 Vaccine Working Group.

Vaccine. 2016 Jul 19;34(33):3796-802. doi: 10.1016/j.vaccine.2016.05.067. Epub 2016 Jun 20.

16.

Individual Correlates of Infectivity of Influenza A Virus Infections in Households.

Tsang TK, Fang VJ, Chan KH, Ip DK, Leung GM, Peiris JS, Cowling BJ, Cauchemez S.

PLoS One. 2016 May 6;11(5):e0154418. doi: 10.1371/journal.pone.0154418. eCollection 2016.

17.

Safety and Upper Respiratory Pharmacokinetics of the Hemagglutinin Stalk-Binding Antibody VIS410 Support Treatment and Prophylaxis Based on Population Modeling of Seasonal Influenza A Outbreaks.

Wollacott AM, Boni MF, Szretter KJ, Sloan SE, Yousofshahi M, Viswanathan K, Bedard S, Hay CA, Smith PF, Shriver Z, Trevejo JM.

EBioMedicine. 2016 Feb 26;5:147-55. doi: 10.1016/j.ebiom.2016.02.021. eCollection 2016 Mar.

18.

Influenza in workplaces: transmission, workers' adherence to sick leave advice and European sick leave recommendations.

Edwards CH, Tomba GS, de Blasio BF.

Eur J Public Health. 2016 Jun;26(3):478-85. doi: 10.1093/eurpub/ckw031. Epub 2016 Apr 9.

19.

Evaluating the effectiveness of localized control strategies to curtail chikungunya.

Ndeffo-Mbah ML, Durham DP, Skrip LA, Nsoesie EO, Brownstein JS, Fish D, Galvani AP.

Sci Rep. 2016 Apr 5;6:23997. doi: 10.1038/srep23997.

20.

Moving interdisciplinary science forward: integrating participatory modelling with mathematical modelling of zoonotic disease in Africa.

Grant C, Lo Iacono G, Dzingirai V, Bett B, Winnebah TR, Atkinson PM.

Infect Dis Poverty. 2016 Feb 25;5:17. doi: 10.1186/s40249-016-0110-4. Review.

Supplemental Content

Support Center